Skip to content
10-Q

Quarterly Report

MediXall Group, Inc.

0001079973-24-000835

← back to feed
Filed
Jun 6, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · May 28, 2024 159.76M sh
Current Liabilities Q2 2023 · Jun 30, 2023 $5.33M
Current Liabilities Q2 2023 · Dec 31, 2022 $4.34M
Total Liabilities Q2 2023 · Jun 30, 2023 $5.33M
Total Liabilities Q2 2023 · Dec 31, 2022 $4.53M
Current Assets Q2 2023 · Jun 30, 2023 $22.06K
Current Assets Q2 2023 · Dec 31, 2022 $11.5K
Total Assets Q2 2023 · Jun 30, 2023 $491.62K
Total Assets Q2 2023 · Dec 31, 2022 $862.01K
Shares Diluted Q2 2023 · Jun 30, 2022 116.15M sh
Shares Diluted Q2 2023 · Jun 30, 2022 115.39M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$2.06M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$1.76M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$675.5K
Stockholders Equity Q2 2023 · Dec 31, 2021 −$340.12K
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.01
Eps Basic Q2 2023 · Jun 30, 2022 −$0.04
Net Income Q2 2023 · Jun 30, 2022 −$1.55M
Net Income Q2 2023 · Jun 30, 2022 −$3.96M
Net Income Q2 2023 · Mar 31, 2022 −$2.41M
Gross Profit Q2 2023 · Jun 30, 2022 $10.35K
Gross Profit Q2 2023 · Jun 30, 2022 $18.26K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $0
Cost Of Revenue Q2 2023 · Jun 30, 2022 $0
Revenue Q2 2023 · Jun 30, 2022 $10.35K
Revenue Q2 2023 · Jun 30, 2022 $18.26K